Abstract CT216: Response to First-Line (1L) Pembrolizumab (pembro) + Chemotherapy (chemo) in Non-Small Cell Lung Cancer (NSCLC) by Blood Tumor Mutational Burden (btmb): the Phase 2 KEYNOTE-782 Trial
Cancer Research(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined